ReviewClinical drug investigation2019

Melatonin and Multiple Sclerosis: From Plausible Neuropharmacological Mechanisms of Action to Experimental and Clinical Evidence.

Mahshid Yeganeh Salehpour et al.PubMed ↗Publisher ↗

No numbers read from the abstract.